Pharmaceuticals

The pharmaceutical industry has always been about the big discovery, invention, blockbuster drugs. With costs escalating on the R&D front, generic drugs taking a share of the market, and health care reform targeting the industry, the pharmaceutical industry has been forced to turn to innovation rather than invention. Looking for new ways to grow their businesses, Strategyn is working with pharmaceutical companies on another front - consumption and use. How drugs are delivered, their messaging and positioning, how they can be used most effectively by consumers ... that's where pharmaceutical companies can differentiate themselves by meeting customer needs.

Our Pharmaceuticals Clients

Acrux Hospira
Lundbeck Hellas Merck Serono
Novozymes Sanofi Aventis
The Medicines Company  

Ingersoll Rand

"It's very valuable to hear (at the Strategyn conference) the experiences from the companies in using and implementing ODI.  What I primarily took from people’s presentations was that many folks have similar problems in gaining buy-in, executing change leadership, and using the results."

Julie Lutz

Kapsch TrafficCom AG

"Outcome-Driven Innovation helps us to identify levers for competitive advantage. We applied this structured approach to review our innovation strategy. Based on these insights, we are able to strengthen and further develop our processes starting from top-level business planning to market communications."

Mag. Martin Eder / MSc

FREE DOWNLOAD - Giving Customers a Fair Hearing

FREE DOWNLOAD - Giving Customers a Fair Hearing

Learn more about Outcome-Driven Innovation by downloading our articles published in MIT Sloan Management Review.

Read More >